BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4043665)

  • 1. Bone loss in autoimmune chronic active hepatitis on maintenance corticosteroid therapy.
    Stellon AJ; Davies A; Compston J; Williams R
    Gastroenterology; 1985 Nov; 89(5):1078-83. PubMed ID: 4043665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microcrystalline hydroxyapatite compound in prevention of bone loss in corticosteroid-treated patients with chronic active hepatitis.
    Stellon A; Davies A; Webb A; Williams R
    Postgrad Med J; 1985 Sep; 61(719):791-6. PubMed ID: 2997764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoporosis in chronic cholestatic liver disease.
    Stellon AJ; Davies A; Compston J; Williams R
    Q J Med; 1985 Nov; 57(223):783-90. PubMed ID: 2934760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis.
    Dempster DW; Arlot MA; Meunier PJ
    Calcif Tissue Int; 1983 Jul; 35(4-5):410-7. PubMed ID: 6616314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen.
    Gallagher JC; Kable WT; Goldgar D
    Am J Med; 1991 Feb; 90(2):171-8. PubMed ID: 1847582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography.
    Rüegsegger P; Medici TC; Anliker M
    Eur J Clin Pharmacol; 1983; 25(5):615-20. PubMed ID: 6662161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation osteoporosis and corticosteroid-induced osteoporosis in autoimmune diseases: experience with alfacalcidol.
    Dequeker J; Borghs H; Van Cleemput J; Nevens F; Verleden G; Nijs J
    Z Rheumatol; 2000; 59 Suppl 1():53-7. PubMed ID: 10769438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrasting microanatomy of idiopathic and corticosteroid-induced osteoporosis.
    Aaron JE; Francis RM; Peacock M; Makins NB
    Clin Orthop Relat Res; 1989 Jun; (243):294-305. PubMed ID: 2721071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroid induced osteoporosis.
    Sambrook PN
    J Rheumatol Suppl; 1996 Aug; 45():19-22. PubMed ID: 8856647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irreversible bone loss in osteomalacia. Comparison of radial photon absorptiometry with iliac bone histomorphometry during treatment.
    Parfitt AM; Rao DS; Stanciu J; Villanueva AR; Kleerekoper M; Frame B
    J Clin Invest; 1985 Dec; 76(6):2403-12. PubMed ID: 4077986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone microarchitecture in males with corticosteroid-induced osteoporosis.
    Chappard D; Josselin N; Rougé-Maillart C; Legrand E; Baslé MF; Audran M
    Osteoporos Int; 2007 Apr; 18(4):487-94. PubMed ID: 17120178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis.
    Stellon AJ; Webb A; Compston JE
    Gut; 1988 Mar; 29(3):378-84. PubMed ID: 3356370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone loss in hypothyroidism with hormone replacement. A histomorphometric study.
    Coindre JM; David JP; Rivière L; Goussot JF; Roger P; de Mascarel A; Meunier PJ
    Arch Intern Med; 1986 Jan; 146(1):48-53. PubMed ID: 3510598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vertebral fracture and cortical bone changes in corticosteroid-induced osteoporosis.
    Tsugeno H; Tsugeno H; Fujita T; Goto B; Sugishita T; Hosaki Y; Ashida K; Mitsunobu F; Tanizaki Y; Shiratori Y
    Osteoporos Int; 2002 Aug; 13(8):650-6. PubMed ID: 12181624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled and oral corticosteroids: their effects on bone mineral density in older adults.
    Marystone JF; Barrett-Connor EL; Morton DJ
    Am J Public Health; 1995 Dec; 85(12):1693-5. PubMed ID: 7503347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study on bone mineral mass in metabolic bone disorders--I-125 photon absorptiometry].
    Kishimoto H
    Nihon Seikeigeka Gakkai Zasshi; 1983 Nov; 57(11):1699-715. PubMed ID: 6676388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of corticosteroids on suppressor-cell activity in "autoimmune" and viral chronic active hepatitis.
    Nouri-Aria KT; Hegarty JE; Alexander GJ; Eddleston AL; Williams R
    N Engl J Med; 1982 Nov; 307(21):1301-4. PubMed ID: 6215581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid-induced fractures and bone loss in patients with asthma.
    Adinoff AD; Hollister JR
    N Engl J Med; 1983 Aug; 309(5):265-8. PubMed ID: 6866051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nutritional supplementation on bone mineral status of children with rheumatic diseases receiving corticosteroid therapy.
    Warady BD; Lindsley CB; Robinson FG; Lukert BP
    J Rheumatol; 1994 Mar; 21(3):530-5. PubMed ID: 8006898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term corticosteroid therapy induces mild changes in trabecular bone texture.
    Lespessailles E; Siroux V; Poupon S; Andriambelosoa N; Pothuaud L; Harba R; Benhamou CL
    J Bone Miner Res; 2000 Apr; 15(4):747-53. PubMed ID: 10780866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.